Furthermore, the expression of NKG2D ligand MICB (Fig. EV8F,G) and chemokines CXCL10 and CCL27 (Fig. EV8H) was increased following treatment of cancer cells with BRD4770. The gene discussed is CXCL10; the disease is cancer.